CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 116 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $298,000 | +308.2% | 162,990 | +499.7% | 0.00% | +300.0% |
| Q1 2022 | $73,000 | -84.3% | 27,180 | -74.7% | 0.00% | -80.0% |
| Q4 2021 | $465,000 | +143.5% | 107,365 | +186.4% | 0.01% | +66.7% |
| Q3 2021 | $191,000 | +15.1% | 37,492 | +43.0% | 0.00% | +50.0% |
| Q2 2021 | $166,000 | -39.2% | 26,224 | -37.2% | 0.00% | -33.3% |
| Q4 2020 | $273,000 | +40.0% | 41,728 | +42.1% | 0.00% | -25.0% |
| Q3 2020 | $195,000 | +42.3% | 29,363 | +78.3% | 0.00% | 0.0% |
| Q2 2020 | $137,000 | -51.4% | 16,470 | -51.4% | 0.00% | -20.0% |
| Q4 2019 | $282,000 | +28.8% | 33,879 | +14.3% | 0.01% | -37.5% |
| Q3 2019 | $219,000 | -6.0% | 29,634 | +43.0% | 0.01% | -11.1% |
| Q2 2019 | $233,000 | – | 20,730 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |